Intelligent anti-epidemic mask based on KF and ECF fusion algorithm.

In response to environmental pollution and the spread of Coronavirus Disease 2019 (COVID-19), this paper proposes a new type of smart mask design, and specifically proposes an optimized double closed-loop control method, especially an improved filtering fusion algorithm. Using the filtering fusion algorithm proposed in this paper, after the Kalman filter (KF) filters the raw data of the attitude sensor, explicit complementary filtering and data fusion are used to obtain the attitude angle of the body. At the same time, the obtained attitude angle is combined with acceleration and blood oxygen concentration to obtain the behaviour characteristic value. On this basis, the speed of the oxygen supply fan captured by the photoelectric sensor is used to form a closed loop with the characteristic value of the behaviour. Finally, the structure of the mask is upgraded and optimized through fluid mechanics simulation, and experiments have verified that the combination of the replaceable filter cloth, the intelligent control system and the ultraviolet disinfection device can effectively protect people's health.

Reciprocating-flowing on-a-chip enables ultra-fast immunobinding for multiplexed rapid ELISA detection of SARS-CoV-2 antibody.

The worldwide epidemic of novel coronavirus disease (COVID-19) has led to a strong demand for highly efficient immunobinding to achieve rapid and accurate on-site detection of SARS-CoV-2 antibodies. However, hour-scale time-consumption is usually required to ensure the adequacy of immunobinding on expensive large instruments in hospitals, and the common false negative or positive results often occur in rapid on-site immunoassay (e.g. immunochromatography). We solved this dilemma by presenting a reciprocating-flowing immunobinding (RF-immunobinding) strategy. RF-immunobinding enabled the antibodies in fluid contacting with the corresponding immobilized antigens on substrate repeatedly during continuous reciprocating-flowing, to achieve adequate immunobinding within 60 s. This strategy was further developed into an immunoassay method for the serological detection of 13 suspected COVID-19 patients. We obtained a 100% true negative and true positive rate and a limit of quantification (LOQ) of 4.14 pg/mL. Our strategy also can be a potential support for other areas related to immunorecognition, such as proteomics, immunopharmacology and immunohistochemistry.